Screener
Artivion AORT Aortic stent grafts — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Artivion in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Artivion’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 1:57 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054746
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Products | $99,905 | $87,444 | $191,347 | $166,242 |
| Preservation services | 25,852 | 25,528 | 50,747 | 45,708 |
| Total revenues | 125,757 | 112,972 | 242,094 | 211,950 |
| Cost of products and preservation services: | ||||
| Products | 33,991 | 28,315 | 63,688 | 53,578 |
| Preservation services | 11,249 | 11,545 | 22,441 | 21,683 |
| Total cost of products and preservation services | 45,240 | 39,860 | 86,129 | 75,261 |
Item 1. Financial Statements.
FAQ
- What is Artivion's aortic stent grafts — total revenues?
- Artivion (AORT) reported aortic stent grafts — total revenues of $46.41M in Q2 2026.
- How has Artivion's aortic stent grafts — total revenues changed year-over-year?
- Artivion's aortic stent grafts — total revenues increased by 16.5% year-over-year, from $39.84M to $46.41M.
- What is the long-term trend for Artivion's aortic stent grafts — total revenues?
- Over 4 years (2021 to 2025), Artivion's aortic stent grafts — total revenues has grown at a 16.9% compound annual growth rate (CAGR), from $85.39M to $159.37M.
- What does aortic stent grafts — total revenues mean?
- This metric represents the total gross revenue generated from the sale of aortic stent graft products within a specific reporting period. It serves as a key indicator of market adoption and commercial performance for the company's specialized endovascular repair portfolio. Investors use this to evaluate the growth trajectory and competitive positioning of the firm's aortic-centric medical device offerings.
Ask your AI about Artivion's aortic stent grafts — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude